About 100 mg Paclitaxel Injection
Experience unparalleled efficacy in cancer care with Paclitaxel Injection 100 mg/16.7 ml, a scarce and first-class antineoplastic solution. Available in a sterile, ready-to-use glass vial, this prescription medicine is engineered for intravenous infusion under valiant medical supervision. Advance purchase secures instant savings for hospitals and clinics requiring dependable supply. It's indicated for the treatment of ovarian, breast, non-small cell lung cancers, and Kaposi's sarcoma. Compatible with PVC systems, the clear, odorless solution must be diluted before use. Cautiously avoid in cases of hypersensitivity to its constituents.
Special Features and Widest Application Areas
Paclitaxel Injection 100 mg/16.7 ml stands out as a first-class, sterile formulation for intravenous infusion used exclusively in oncology. Its distinct compatibility with PVC containers and user-friendly dilution process makes it highly versatile. Ideal for application in advanced hospitals, cancer centers, and clinics, it is prescribed by experienced oncologists for valiant treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma. Stock is limited; advance purchase ensures immediate therapy for patients in need.
Payment Terms, Export & Domestic Markets for Paclitaxel Injection
Competitive outlay options and seamless payment terms ease procurement for both local and international buyers of Paclitaxel Injection 100 mg/16.7 ml. With stock ready and available for prompt dispatch, major export destinations include Southeast Asia, Middle East, Africa, and key Western markets. Freight can be arranged per client instruction, ensuring timely delivery. Domestically, the injection is trusted by top-tier medical institutions throughout India, solidifying its reputation as a reliable solution in specialized oncology care.
FAQ's of 100 mg Paclitaxel Injection:
Q: How should Paclitaxel Injection 100 mg/16.7 ml be prepared and administered?
A: Paclitaxel Injection requires dilution before intravenous infusion. It must only be administered by qualified healthcare professionals in a clinical setting, using compatible PVC containers and infusion sets.
Q: What cancers can be treated with this injection?
A: Paclitaxel Injection is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma, offering a versatile antineoplastic solution.
Q: When is advance purchase of Paclitaxel Injection recommended?
A: Due to its scarce availability and high demand in oncology, advance purchase is advised to ensure instant savings and uninterrupted cancer therapy supply.
Q: Where should Paclitaxel Injection be stored for optimal shelf life?
A: It should be stored below 25C, protected from light, and kept in its glass vial to maintain a 24-month shelf life and stability.
Q: What are the main features that set this injection apart?
A: The injection is ready-to-use, sterile, and compatible with standard PVC infusion systems. Its clear, odorless formulation and multi-dose packaging offer convenience and safety in clinical settings.
Q: Who should avoid the use of Paclitaxel Injection?
A: Individuals with hypersensitivity to paclitaxel or polyoxyethylated castor oil should not use this injection, as severe allergic reactions may occur.